Literature DB >> 25815853

Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.

Yan Li1, Ilwoo Park, Sarah J Nelson.   

Abstract

Magnetic resonance spectroscopy (MRS) is a powerful tool for noninvasively investigating normal and abnormal metabolism. When used in combination with imaging strategies, multinuclear MRS methods provide detailed biochemical information that can be directly correlated with anatomical features. Hyperpolarized C MRS is a new technology that reflects real-time metabolic conversion and is likely to be extremely valuable in managing patients with cancer. This article reviews the use of in vivo P, H, and C MRS for assessing cancer metabolism in order to provide information for diagnosis, planning treatment, assessing response to therapy, and predicting survival for patients with cancer.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25815853      PMCID： PMC4429803          DOI： 10.1097/PPO.0000000000000097

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


  36 in total

1.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Authors:  Radhika Srinivasan; Joanna J Phillips; Scott R Vandenberg; Mei-Yin C Polley; Gabriela Bourne; Alvin Au; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-07-20       Impact factor: 12.300

2.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T.

Authors:  Ralf Mekle; Vladimír Mlynárik; Giulio Gambarota; Martin Hergt; Gunnar Krueger; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

3.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.

Authors:  Simon Hu; Asha Balakrishnan; Robert A Bok; Brittany Anderton; Peder E Z Larson; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Andrei Goga
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

Review 4.  Glutamine addiction: a new therapeutic target in cancer.

Authors:  David R Wise; Craig B Thompson
Journal:  Trends Biochem Sci       Date:  2010-08       Impact factor: 13.807

5.  Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients.

Authors:  Ilwoo Park; Albert P Chen; Matthew L Zierhut; Esin Ozturk-Isik; Daniel B Vigneron; Sarah J Nelson
Journal:  Ann Biomed Eng       Date:  2010-07-23       Impact factor: 3.934

6.  Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging.

Authors:  Ilwoo Park; Robert Bok; Tomoko Ozawa; Joanna J Phillips; C David James; Daniel B Vigneron; Sabrina M Ronen; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

7.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

Review 8.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

9.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Authors:  Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; Julien Laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khe Hoang-Xuan; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079
View more
  14 in total

Review 1.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

Review 2.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

Review 3.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

Review 4.  The Potential of Metabolic Imaging.

Authors:  Valentina Di Gialleonardo; David M Wilson; Kayvan R Keshari
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

Review 5.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

6.  Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.

Authors:  Evan Neill; Tracy Luks; Manisha Dayal; Joanna J Phillips; Arie Perry; Llewellyn E Jalbert; Soonmee Cha; Annette Molinaro; Susan M Chang; Sarah J Nelson
Journal:  J Neurooncol       Date:  2017-01-25       Impact factor: 4.130

7.  Tumor metabolism and neurocognition in CNS lymphoma.

Authors:  Huimin Geng; Mazie Tsang; Lakshmipriya Subbaraj; Joseph Cleveland; Lingjing Chen; Ming Lu; Jigyasa Sharma; Daniel B Vigneron; John Kurhanewicz; Marisa LaFontaine; Tracy Luks; Bruce A Barshop; Jon Gangoiti; Javier E Villanueva-Meyer; James L Rubenstein
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 12.300

8.  Direct and cost-efficient hyperpolarization of long-lived nuclear spin states on universal (15)N2-diazirine molecular tags.

Authors:  Thomas Theis; Gerardo X Ortiz; Angus W J Logan; Kevin E Claytor; Yesu Feng; William P Huhn; Volker Blum; Steven J Malcolmson; Eduard Y Chekmenev; Qiu Wang; Warren S Warren
Journal:  Sci Adv       Date:  2016-03-25       Impact factor: 14.136

9.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

10.  MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.

Authors:  Abigail R Molloy; Chloé Najac; Pavithra Viswanath; Aliya Lakhani; Elavarasan Subramani; Georgios Batsios; Marina Radoul; Anne Marie Gillespie; Russell O Pieper; Sabrina M Ronen
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.